S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00288054 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

NETWORK

Sponsor class

Stopped Study closed early due to poor accrual.

Conditions

Lung Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: docetaxel
RADIATION: radiation therapy

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]